← Back to Search

Cannabis Effects for Elder Care Services

Phase 1
Waitlist Available
Led By Alison Oliveto, PhD
Research Sponsored by University of Arkansas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-drug and 1, 2, 3, and 5.5 hours post-drug administration
Awards & highlights
No Placebo-Only Group

Summary

This trial studied how marijuana affects mood, thinking, movement, balance, and heart rate in older people.

Who is the study for?
This trial is for older adults who have not used psychoactive drugs, tobacco, or cannabis recently. They must be in stable health with controlled medical conditions and no history of serious substance abuse or cognitive disorders. Women must be post-menopausal or not capable of bearing children.
What is being tested?
The study tests the effects of up to three doses of cannabis on mood, cognition, psychomotor performance, balance, and vital signs in older adults to understand how it affects them differently than younger populations.
What are the potential side effects?
Potential side effects from cannabis use may include changes in mood and perception, dizziness or balance issues, altered cognitive function and psychomotor performance which could affect tasks like driving.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-drug and 1, 2, 3, and 5.5 hours post-drug administration
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-drug and 1, 2, 3, and 5.5 hours post-drug administration for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Balance Tests - 30 sec chair-stand
Balance Tests - Four-Stage
Balance Tests - Timed Up and Go
+8 more
Secondary study objectives
Cognitive Function Tests - Auditory learning
Cognitive Function Tests - Card Sort
Cognitive Function Tests - Flanker
+6 more
Other study objectives
Acceptability - AEs
Acceptability - duration of assessments
Acceptability - food
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Cannabis (up to three doses)Experimental Treatment1 Intervention
Brownies containing a dose of cannabis

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

University of ArkansasLead Sponsor
495 Previous Clinical Trials
150,365 Total Patients Enrolled
Alison Oliveto, PhDPrincipal InvestigatorUniversity of Arkansas
8 Previous Clinical Trials
488 Total Patients Enrolled
~NaN spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top